| products | technology | press | careers | |||||||||||
![]() |
||||||||||||||
| in the news | ||||||||||||||
|
Wave 80, Siemens team up on HIV viral load measurement With NIH support, initiative seeks to develop innovative tools for guiding antiretroviral therapy San Francisco, California and Tarrytown, New York, October 19, 2007 Targeting a major area of need in the global fight against HIV/AIDS, Wave 80 and Siemens Medical Solutions Diagnostics today announced the beginning of a new research initiative focused on technologies to complement pharmaceutical strategies for helping patients diagnosed with HIV lead longer, more productive lives. Wave 80 to make EOSCAPE assay cartridge technology kernel available for out-license Innovative, low-cost technology offers high-temporal-resolution control over transport of samples and reagents within disposable assay cartridges “The decision to outlicense the EOSCAPE kernel reflects the continued strengthening and diversification of Wave 80’s technology portfolio as well as the persistent need for better, cheaper, and faster diagnostics in key disease classes,” said Dr. Daniel Laser, Wave 80’s CEO. “Broad dissemination of EOSCAPE is vital for allowing physicians and patients to benefit from the wide variety of new diagnostics products this technology enables.” Wave 80 malaria diagnostic selected for oral presentation at prestigious Emerging technologies forum will showcase research on ultraminature device for measuring disease markers in fingerstick blood samples |
||||||||||||||
copyright 2008 wave 80 biosciences, inc. san francisco, california |
||||||||||||||